Page last updated: 2024-11-03

procarbazine and Reperfusion Injury

procarbazine has been researched along with Reperfusion Injury in 1 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaur, H1

Reviews

1 review available for procarbazine and Reperfusion Injury

ArticleYear
A water soluble C-nitroso-aromatic spin-trap-3,5-dibromo-4-nitrosobenzenesulphonic acid. "The Perkins spin-trap'.
    Free radical research, 1996, Volume: 24, Issue:6

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Benzenesulfonates; Carbohydrates; Coumarins; Free R

1996